» Articles » PMID: 28984039

Small Molecule Antagonist of Cell Surface Glycosaminoglycans Restricts Mouse Embryonic Stem Cells in a Pluripotent State

Overview
Journal Stem Cells
Date 2017 Oct 7
PMID 28984039
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Recently, the field of stem cell-based regeneration has turned its attention toward chemical approaches for controlling the pluripotency and differentiation of embryonic stem cells (ESCs) using drug-like small molecule modulators. Growth factor receptors or their associated downstream kinases that regulate intracellular signaling pathways during differentiation are typically the targets for these molecules. The glycocalyx, which plays an essential role in actuating responses to growth factors at the cellular boundary, offers an underexplored opportunity for intervention using small molecules to influence differentiation. Here, we show that surfen, an antagonist of cell-surface glycosaminoglycans required for growth factor association with cognate receptors, acts as a potent and general inhibitor of differentiation and promoter of pluripotency in mouse ESCs. This finding shows that drugging the stem cell Glycome with small molecules to silence differentiation cues can provide a powerful new alternative to existing techniques for controlling stem cell fate. Stem Cells 2018;36:45-54.

Citing Articles

Mapping the FGF2 Interactome Identifies a Functional Proteoglycan Coreceptor.

Critcher M, Pang J, Huang M ACS Chem Biol. 2024; 20(1):105-116.

PMID: 39704408 PMC: 11858877. DOI: 10.1021/acschembio.4c00475.


Molecular Dynamics Simulation-Based Prediction of Glycosaminoglycan Interactions with Drug Molecules.

Maszota-Zieleniak M, Samsonov S Methods Mol Biol. 2023; 2714:143-153.

PMID: 37676597 DOI: 10.1007/978-1-0716-3441-7_8.


N-Acetylcysteine and Other Sulfur-Donors as a Preventative and Adjunct Therapy for COVID-19.

du Preez H, Aldous C, Kruger H, Johnson L Adv Pharmacol Pharm Sci. 2022; 2022:4555490.

PMID: 35992575 PMC: 9385285. DOI: 10.1155/2022/4555490.


The neutralization of heparan sulfate by heparin-binding copolymer as a potential therapeutic target.

Kalaska B, Miklosz J, Kaminski K, Musielak B, Yusa S, Pawlak D RSC Adv. 2022; 9(6):3020-3029.

PMID: 35518950 PMC: 9059929. DOI: 10.1039/c8ra09724k.


Proteoglycans and Glycosaminoglycans in Stem Cell Homeostasis and Bone Tissue Regeneration.

Chen J, Sun T, You Y, Wu B, Wang X, Wu J Front Cell Dev Biol. 2021; 9:760532.

PMID: 34917612 PMC: 8669051. DOI: 10.3389/fcell.2021.760532.


References
1.
Kraushaar D, Yamaguchi Y, Wang L . Heparan sulfate is required for embryonic stem cells to exit from self-renewal. J Biol Chem. 2009; 285(8):5907-16. PMC: 2820816. DOI: 10.1074/jbc.M109.066837. View

2.
Yayon A, Klagsbrun M, Esko J, Leder P, Ornitz D . Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell. 1991; 64(4):841-8. DOI: 10.1016/0092-8674(91)90512-w. View

3.
Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K . In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature. 2007; 448(7151):318-24. DOI: 10.1038/nature05944. View

4.
Nicola N, Babon J . Leukemia inhibitory factor (LIF). Cytokine Growth Factor Rev. 2015; 26(5):533-44. PMC: 4581962. DOI: 10.1016/j.cytogfr.2015.07.001. View

5.
Rapraeger A, Krufka A, Olwin B . Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science. 1991; 252(5013):1705-8. DOI: 10.1126/science.1646484. View